Powder Delivery TRIZ Cases

Inhaled interferon activates mucosal immunity to reduce viral transmission and symptom severity without systemic administration complexity.

A polymer carrier improves pharmaceutical solubility and epithelial permeability for better drug delivery.

Prefabricated holes in the capsule eliminate piercing inconsistencies, ensuring reproducible atomization.

Coordination-linked platinum compounds on polymeric carriers reduce nephrotoxicity while maintaining anti-tumor potency.

Replacing ethyl alcohol with ethyl lactate in an oily fulvestrant formulation reduces injection site irritation while maintaining sustained drug release.

Rotating receptacle drying eliminates non-uniform heat transfer variations in Factor VIII production.

A topical wound treatment composition disperses a hydrogen peroxide generator and alkaline powder in an emollient to generate oxygen upon water diffusion.

Crosslinked poly-fluoroacrylic acid polymers remove potassium ions from the gastrointestinal tract, reducing serum levels without severe side effects.

A surfactant reduces surface tension in freeze-dried fish gelatin formulations to enable free flow into preformed molds.

Lyophilization prepares sterile gellan gum to meet cGMP regulations, avoiding complex point-of-use sterilization.

Encapsulated silica particles within polymer micelles preserve antioxidant activity in acidic environments, enabling targeted intestinal drug delivery.

Lyophilized pluripotent stem cells reverse aging effects without immune rejection risks.

Fluorocarbon-filled photosensitizer particles deliver oxygen to hypoxic tumors while providing ultrasound and MRI contrast.

Cleavable amine groups enable efficient siRNA binding and release, avoiding immunogenicity.

Solid carrier stabilizes epinephrine powder, eliminating needle risks and complex deagglomeration devices.

Synthetic metal nanoparticles resolve production complexity and side effects by enabling effective treatment at nanomolar concentrations.

DTPA or NOTA chelating sites in the polypeptide structure enhance GLP-1R affinity, resolving limited binding issues in insulinoma imaging.

A polyisocyanate and diol reaction coats porous magnetic polymer particles, physically encapsulating superparamagnetic crystals to prevent leaching.

Replacing DNA with modified RNA eliminates insertional mutagenesis risks while inducing robust immune responses.

High-Z gold nanorods concentrate ionizing radiation energy within tumor tissue to amplify DNA damage and improve radiosensitization.

Vesicle encapsulation controls precursor distribution, enabling homogeneous nano-particles with fast-reacting alkoxides.

A nanocontainer design uses a lipophilic core and hydrophilic hybrid shell to solve solubility contradictions for drug delivery.

Spray-dried particles with high tapped density suspend in a vehicle, enabling high API concentrations while maintaining low injection forces.

Covalently coupled stabilizing agents form hybrid lipid bilayers around nanoparticle cores to enhance stability and biodistribution.

Gamma-carboxy glutamic acid peptides bind calcium ions to detach mucus from epithelial surfaces, resolving stagnation in respiratory disorders.

Strontium phosphate microparticles bond radioisotopes via chemical conversion of borate glass carriers.

Direct reduction of gold precursors by insulin eliminates ligand substitution steps, preserving protein activity and enabling precise adipose cell detection.

Fc-specific peptides expand natural regulatory T cells to treat Kawasaki disease, offering a cost-effective alternative to IVIG therapy.

Ultrasound treatment increases crystallinity of solid materials during spray drying to produce dry powder inhaler particles.

Magneto-plasmonic nanoparticles cross the blood-brain barrier under magnetic guidance and release drugs via near-infrared light.

A porous matrix tissue scaffold enables controlled cell seeding and nutrient diffusion through a fluid-state slurry process.

Chelated drug delivery systems release minocycline through polyelectrolyte-metal complexes to reduce inflammation around neural prostheses.

Replacing polysorbate 80 and mannitol with lysozyme complexes reduces bronchospasm risks while maintaining aerosol suspension stability.

Micromixers enable aqueous coprecipitation of magnetic iron oxide nanoparticles, eliminating organic solvent consumption and aggregation.

Ultrasonic spray dissolves probiotics in methanol to form nanoparticles, eliminating toxic byproducts from chemical synthesis while reducing oxidative stress.

Hydrogenated starch hydrosylate protects therapeutic agents from environmental destabilization during storage and pulmonary delivery.

Covalent taxoid conjugation with functionalized copolymers resolves solubility and release control contradictions via hydrolyzable linkers.

Nanoparticle conjugation improves bispecific antibody pharmacokinetics and stability while reducing immunogenicity.

KOC1-derived peptides induce cytotoxic T cells against tumor cells, addressing HLA restriction limits in cancer immunotherapy.

A PVP-VA copolymer binder combined with a plasticizer reduces the glass transition temperature, enabling direct compression of poorly compressible drugs.

Wet grinding organic compounds at specific pH levels generates sufficient zeta potential to maintain suspension stability without external stabilizers.

Segmented compartments with acid-labile coatings and retardants enable prolonged, linear release of active substances despite differing solubility profiles.

Inherently radiopaque side-chain crystallizable polymers incorporate heavy atoms into polymer chains to enable precise medical device detection.

A nucleic acid-based vaccine induces antigen-specific immune responses through lipid nanoparticle delivery.

Core-shell nanoparticles deliver multiple chemotherapeutics via cleavable prodrugs, reducing side effects from non-selective distribution.